Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia

Get in touch with RARE Concierge.

Contact RARE Concierge

Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia

Synonyms: G6P deficiency type 1a | GSD due to G6P deficiency type 1a | GSD due to G6P deficiency type Ia | GSD type 1a | GSDIa | Glycogen storage disease due to G6P deficiency type Ia | Glycogen storage disease type 1a | Glycogenosis due to glucose-6-phosphatase deficiency type 1a | Glycogenosis due to glucose-6-phosphatase deficiency type Ia | Glycogenosis type Ia

Glycogenosis due to glucose-6-phosphatase deficiency (G6P) type a or glycogen storage disease (GSD) type 1a is a type of glycogenosis due to G6P deficiency (see this term).

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

association for glycogen storage disease

The Association for Glycogen Storage Disease (AGSD) is a patient advocacy organization dedicated to protecting and promoting the best interest of all persons affected by the glycogen storage disease. • AGSD is committed to the identification, treatment, and cure of glycogen storage disease through programs of education, advocacy, research, and patient services.

Clinical Trials

For a list of clinical trials in this disease area, please click here.